Personalized Medicine Market, By Application (Therapeutics and Diagnostics), By Indication (Oncology, Immunology, Neurology, Cardiology, Autoimmune Diseases, and Others), By End User (Hospital & Clinics, Diagnostic Laboratories, Academic & Research Instit
Personalized Medicine Market, By Application (Therapeutics and Diagnostics), By Indication (Oncology, Immunology, Neurology, Cardiology, Autoimmune Diseases, and Others), By End User (Hospital & Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)
Personalized medicine aims to tailor healthcare to the individual characteristics of each patient, providing targeted treatment based on genetics, biomarkers, and clinical risk factors. It represents an evolution from a one-size-fits-all approach to treatment and disease prevention to a highly customized system that considers individual variability in patients' genes, environments, and lifestyles. Personalized medicine has the potential to reduce adverse drug reactions, enhance treatment efficacy, and improve health outcomes through better-informed medical decisions. With advancements in genetic testing, big data analytics and molecular diagnostics, it enables physicians to genetically profile patients' susceptibility to specific diseases and optimize therapies accordingly. This emerging field is transforming how diseases are diagnosed, treated, and prevented on an individual level.
Market Dynamics:
The personalized medicine market is driven by factors such as rising healthcare costs and drug development costs for pharmaceutical companies, increasing demand for targeted therapies, growing prominence of companion diagnostics, rising focus on precision medicine, and availability of genetic data for research. However, lack of awareness about this approach among patients and physicians, high upfront costs, and regulatory issues hinder the growth of this market. Developing healthcare infrastructure in emerging economies provides significant growth opportunities for market players. Market leaders are investing in big data analytics and collaborating with diagnostic testing companies to develop combination products for better patient outcomes. Continued research in pharmacogenomics and companion diagnostics will further expand the capabilities of personalized medicine over the next decade.
Key Features of the Study:
This report provides an in-depth analysis of the global personalized medicine market, and provides market size (USD BN) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global personalized medicine market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study includes Precision Biologics, Danaher Corporation, Abbott, Illumina, Inc., Exact Sciences Corporation, ASURAGEN, INC., Exagen Inc., Genentech, Inc., Berg Health, Omada Health, Natera, Invitae, Myriad Genetics, Celcuity, InsightRX, and Axial3D
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global personalized medicine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global personalized medicine market
Detailed Segmentation-
Application:
Therapeutics
Nutrition & Wellness
Diagnostics
Others
Indication:
Oncology
Immunology
Neurology
Cardiology
Autoimmune Diseases
Others
End User:
Hospital & Clinics
Diagnostic Laboratories
Academic & Research Institutes
Others
Region:
North America
Europe
Asia Pacific
Latin America
Middle East
Africa
Company Profiles:
Precision Biologics
Danaher Corporation
Abbott
Illumina, Inc.
Exact Sciences Corporation
ASURAGEN, INC.
Exagen Inc.
Genentech, Inc.
Berg Health
Omada Health
Natera
Invitae
Myriad Genetics
Celcuity
InsightRX
Axial3D
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Facility Type
Market Snapshot, By Ownership
Market Snapshot, By Service Offered
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Market Trends
Recent Developments
Acquisitions and Partnerships Scenario
Technology Overview
Regulatory Scenario
Pricing Analysis
PEST Analysis
4. Global Skilled Nursing Facility Market - Impact of Coronavirus (COVID-19) Pandemic
Overall Impact
Government Initiatives
COVID-19 impact on the market
5. Global Skilled Nursing Facility Market, By Facility Type, 2019 – 2031, (USD BN)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2019 – 2031
Segment Trends
Government
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
Freestanding
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
6. Global Skilled Nursing Facility Market, By Ownership, 2019 – 2031, (USD BN)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2019 – 2031
Segment Trends
Government
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
Profit
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
Non-Profit
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
7. Global Skilled Nursing Facility Market, By Service Offered, 2019 – 2031, (USD BN)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2019 – 2031
Segment Trends
Physical Therapy
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
Occupational Therapy
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
Speech-language Pathology Services
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
Medical Social Services
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
Others
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
8. Global Skilled Nursing Facility Market, By Region, 2019 – 2031, (USD BN)
Introduction
Market Share Analysis, By Region, 2024 and 2031 (%)
Y-o-Y Growth Analysis, For Region, 2019–2031
Regional Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Facility Type, 2019 - 2031, (USD BN)
Market Size and Forecast, and Y-o-Y Growth, By Ownership, 2019 - 2031, (USD BN)
Market Size and Forecast, and Y-o-Y Growth, By Service Offered, 2019 - 2031, (USD BN)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD BN)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Facility Type, 2019 - 2031, (USD BN)
Market Size and Forecast, and Y-o-Y Growth, By Ownership, 2019 - 2031, (USD BN)
Market Size and Forecast, and Y-o-Y Growth, By Service Offered, 2019 - 2031, (USD BN)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD BN)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Facility Type, 2019 - 2031, (USD BN)
Market Size and Forecast, and Y-o-Y Growth, By Ownership, 2019 - 2031, (USD BN)
Market Size and Forecast, and Y-o-Y Growth, By Service Offered, 2019 - 2031, (USD BN)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD BN)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Facility Type, 2019 - 2031, (USD BN)
Market Size and Forecast, and Y-o-Y Growth, By Ownership, 2019 - 2031, (USD BN)
Market Size and Forecast, and Y-o-Y Growth, By Service Offered, 2019 - 2031, (USD BN)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD BN)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Facility Type, 2019 - 2031, (USD BN)
Market Size and Forecast, and Y-o-Y Growth, By Ownership, 2019 - 2031, (USD BN)
Market Size and Forecast, and Y-o-Y Growth, By Service Offered, 2019 - 2031, (USD BN)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD BN)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Facility Type, 2019 - 2031, (USD BN)
Market Size and Forecast, and Y-o-Y Growth, By Ownership, 2019 - 2031, (USD BN)
Market Size and Forecast, and Y-o-Y Growth, By Service Offered, 2019 - 2031, (USD BN)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 – 2031, (USD BN)
North Africa
Central Africa
South Africa
9. Competitive Landscape
Company Profiles
Consulate Health Care
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Atria senior living
HCR ManorCare
The Riverview Care Center
Kindred Healthcare, LLC
ProMedica Senior Care
Erickson Living
Ensign Group
Fundamental healthcare
Signature healthcare
Genesis HealthCare
Life Care Centers of America
Trilogy Health Services LLC
Saber Healthcare Group
Providence Group
Life Care Services
10. Analyst View
Wheel of Fortune
Analyst View
Coherent Opportunity Map
11. References and Research Methodology
References
Research Methodology
About us and Sales Contact
*Browse 24 market data tables and 34 figures on Skilled Nursing Facility Market” - Global forecast to 2031